You should have joined the presentation this morning and then it would have made sense.
Three (3) of the indications out of Four(4) were fully funded through Phase II. But Prader Willi wasn't and Jon stated they got a massive response when Prader Willi got Orphan Drug status and wanted it moved along more quickly (which it could be done in parallel).
Additionally for those of you that have been on the register since 2018, you will remember there was one year in between Phase II readout on Trofinetide and Phase III starting. This is because they only had the money to do Phase II and not all the preparation work for Phase III (maybe they also saw the risk higher?).. With these 4 indications they seem to be very bullish because they would like to do all the preparations (Jon explained what they were on the call) in parallel to doing the Phase II so a Phase III could start as soon as possible after Phase II was completed.
Extremely bullish in my opinion on both points.
Ann: Proposed issue of securities - NEU, page-18
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.50 |
Change
0.190(0.98%) |
Mkt cap ! $2.490B | |||
| Open | High | Low | Value | Volume |
| $19.39 | $19.98 | $19.38 | $7.285M | 370.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 7318 | $19.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.52 | 593 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.55 |
Change
0.190 ( 0.83 %) |
||||
| Open | High | Low | Volume | ||
| $19.41 | $19.97 | $19.39 | 83274 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| NEU (ASX) Chart |